ISFIYA, Israel, Aug. 29, 2018 /PRNewswire/ -- Check-Cap Ltd.
(the "Company" or "Check-Cap") (NASDAQ: CHEK) (NASDAQ: CHEKW) (NASDAQ: CHEKZ), a clinical stage medical diagnostics company
engaged in the development of C-Scan®, an ingestible capsule-based device for preparation-free colorectal cancer screening, today
announced it will be featured as a presenting company at the 20th Annual Rodman & Renshaw Global Investment
Conference, sponsored by H.C. Wainwright & Co., LLC. The conference is being held on September 4-6, 2018 at the St. Regis New York Hotel in New York City.
Alex Ovadia, Chief Executive Officer of Check-Cap, will provide an overview of the Company's
business during the live presentation and will be available to participate in one-on-one meetings with investors who are
registered to attend the conference.
If you are an institutional investor, and would like to attend the Company's presentation, please click on the following link
(www.rodmanevents.com ) to register for the
conference. Once your registration is confirmed, you will be prompted to log into the conference website to request a
one-on-one meeting with the Company.
Event: Check-Cap Presentation
Date: Wednesday, September 5, 2018
Time: 3:00 p.m. EDT
Location: Library, 2nd Floor; St. Regis New York Hotel
To access a live webcast of this presentation, please visit http://ir.check-cap.com/events-and-presentations. A replay
will be available for 90 days following the presentation.
About Check-Cap
Check-Cap is a clinical-stage medical diagnostics company developing C-Scan®, an ingestible capsule-based device for
preparation-free colorectal cancer screening.
Utilizing innovative ultra-low dose X-ray and wireless communication technologies, the capsule generates information on the
contours of the inside of the colon as it passes naturally. This information is used to create a 3D map of the colon, which
allows physicians to look for polyps and other abnormalities. Designed to improve the patient experience and increase the
willingness of individuals to participate in recommended colorectal cancer screening, C-Scan removes many frequently-cited
barriers, such as laxative bowel preparation, invasiveness and sedation.
Legal Notice Regarding Forward-Looking Statements
This press release contains "forward-looking statements." Words such as "may," "should," "could," "would," "predicts,"
"potential," "continue," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates," and similar
expressions, as well as statements in future tense, often signify forward-looking statements. Forward-looking statements should
not be read as a guarantee of future performance or results and may not be accurate indications of when such performance or
results will be achieved. Forward-looking statements are based on information that the Company has when those statements are made
or management's good faith belief as of that time with respect to future events, and are subject to risks and uncertainties that
could cause actual performance or results to differ materially from those expressed in or suggested by the forward-looking
statements. For a discussion of these and other risks that could cause such differences and that may affect the realization of
forward-looking statements, please refer to "Forward-looking Statements" and "Risk Factors" in the Company's Annual Report on
Form 20-F for its fiscal year ended December 31, 2017 and other filings with the Securities and
Exchange Commission (SEC). Investors and security holders are urged to read these documents free of charge on the SEC's web site
at http://www.sec.gov. The Company assumes no obligation to publicly update or
revise its forward-looking statements as a result of new information, future events or otherwise.
Investor Contacts
Vivian Cervantes
PCG Advisory
+1-646-863-6274
vivian@pcgadvisory.com
Meirav Gomeh-Bauer
+972-54-4764979
Meirav@bauerg.com
View original content with multimedia:http://www.prnewswire.com/news-releases/check-cap-announces-participation-at-the-20th-annual-rodman--renshaw-global-investment-conference-300703986.html
SOURCE Check-Cap Ltd.